Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats.
about
Lack of abuse potential in a highly selective dopamine D3 agonist, PF-592,379, in drug self-administration and drug discrimination in ratsRecent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug developmentDopamine D4 receptors in psychostimulant addictionPharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addictionThe selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in ratsDopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humansExpression of functional cannabinoid CB2 receptor in VTA dopamine neurons in ratsEvidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in miceStimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutationEffects of chronic binge-like ethanol consumption on cocaine self-administration in rhesus monkeys.The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J micePhenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in ratsNeuronal circuitry underlying the impact of D3 receptor ligands in drug addiction.Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.Anti-relapse medications: preclinical models for drug addiction treatment.The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications.Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in ratsDopamine D1 and D3 receptors mediate reconsolidation of cocaine memories in mouse models of drug self-administrationIncreased vulnerability to cocaine in mice lacking dopamine D3 receptorsModification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and ratsCurrent perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs.The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.Blockade of dopamine D3 receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in ratsThe dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference.Effects of chronic buspirone treatment on cocaine self-administrationA selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in miceCocaine self-administration in dopamine D₃ receptor knockout mice.Dopamine D3 receptor ligands for the treatment of tobacco dependence.Dopamine D3 receptors regulate reconsolidation of cocaine memory.Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats.The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats.The selective D₃ receptor antagonist SB-277011A attenuates morphine-triggered reactivation of expression of cocaine-induced conditioned place preferencePG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats
P2860
Q24614563-AB41245A-B52E-4684-AADD-05FFFE1424D4Q27014737-463B42A5-E0D8-4F01-87B9-B82B9487C6EAQ27026759-89EFAC02-7FBB-4F96-95CD-4784CA0026C5Q28236375-2CB9FB6E-7310-48E5-B4CB-8BAB3BE9C672Q28256384-A153B757-E0A5-4A78-8E08-321833F41A25Q28265851-54ED45EA-5300-40DA-82F8-BD50FD8B8095Q28272826-CC6A6CE6-4F5B-454A-86F3-0DC4BDBCF880Q28296440-571F1750-8C77-4BA4-9EC6-8C6E029616E6Q28301428-DF91C57B-E9D5-446A-A967-881C19A7A207Q30377582-3DAF4881-1C40-45A2-A528-6D7155DDF53DQ30476573-666B0D22-DF7B-45DE-B33B-43AE24DB3ADFQ30581703-DD837BCE-F6F9-49B1-8AAD-1511BB8EEC82Q30855960-39FE344D-02AB-42E4-BC50-908FCDC1160DQ33697312-8C5B02CC-14BB-4F46-9ABD-5E4E8D15C1EFQ33927470-A7C67BB4-45CA-4E98-B116-8BDE183070F0Q33992366-27C1AB94-1DF5-43C3-9217-D0F1C118B5F8Q34136977-ED7F8D28-0798-4FD7-A7C7-0ABB8A0378AFQ34209414-7BA854B8-555A-49D2-872D-6A184444065DQ34231896-0CC57527-A3E0-4F17-977E-3F89627A9C18Q34304643-7B72F229-599D-421C-9081-E33E35710B13Q34640741-E653D578-27FD-4A4F-B2A7-A409AD89AD54Q34982537-CABE9347-CD10-4F79-9101-8B11399BEFC6Q35089428-381B1F96-BD91-4076-8686-A138920B4502Q35143623-581C7128-E197-45CE-A25D-3D859D50673BQ35892818-DCE7DED2-C8C3-4BC7-A809-F8490E6A33A8Q35962024-D8860E8C-E998-4E30-830F-76AD11291596Q36248887-FFA0F867-3260-451A-9573-046BD179A7DBQ36431345-B52CD398-80F5-4F99-B759-B799D3CFF882Q36494884-66497375-BB11-4777-988F-AE6EE645E879Q36540036-AA8DECD6-3D59-4D40-86EA-9B2BA3938791Q36579310-4D5D39E2-899F-46FD-8139-8C1F42867CD5Q36655271-A099787F-9B90-4D26-8DBF-BB99D1560A7AQ36677397-A9C046CA-F740-492B-911E-899A1DA4719EQ36823743-8EA00046-8236-4FA3-BFCD-31AEB972D495Q36877182-259C741D-F335-4F89-9965-41C1E3A23E11Q36952858-CC8E3311-DFCD-4E57-A7E8-0FCF40555F1BQ37052544-5D2F68DF-3270-49B6-9813-3A7AD988204BQ37057438-7F0C3EA0-3498-49E3-B5D8-36E7E705E3F5Q37057993-C52242B9-1B6F-4D53-8D28-262FE10DD2D8Q37060818-109B52A5-1E4A-4C06-9429-F16AC0201BA1
P2860
Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective dopamine D3 receptor ...... e self-administration in rats.
@en
Selective dopamine D3 receptor ...... e self-administration in rats.
@nl
type
label
Selective dopamine D3 receptor ...... e self-administration in rats.
@en
Selective dopamine D3 receptor ...... e self-administration in rats.
@nl
prefLabel
Selective dopamine D3 receptor ...... e self-administration in rats.
@en
Selective dopamine D3 receptor ...... e self-administration in rats.
@nl
P2093
P2860
P1476
Selective dopamine D3 receptor ...... e self-administration in rats.
@en
P2093
Arlene C Pak
Charles R Ashby
Christian A Heidbreder
Eliot L Gardner
Jeremy G Gilbert
Zheng-Xiong Xi
P2860
P304
P356
10.1111/J.1460-9568.2005.04159.X
P407
P577
2005-06-01T00:00:00Z